Lupin Ltd.
Clinical trials sponsored by Lupin Ltd., explained in plain language.
Lupin Ltd.
LUPIN
NSE
Global pharmaceutical company producing generic and branded medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study tests safer version of muscle stiffness drug Results expected Jan 2027 (estimated)